D-Tails Srl SB is an Italian deep-tech life science company building a data-generating platform for AI-ready human biology, with early cancer detection as its first clinical application.
A portable, non-invasive device combining VOC detection, engineered C. elegans receptors, a bioluminescent signal, and AI-based interpretation — delivering a rapid result on potential cancer presence.
Integrated screening services for clinical partners — from large-scale program support and validation workflows to data and AI services as the platform scales.
D-Tails combines living biological sensing, advanced optical readout, and AI-based behavioral interpretation to identify cancer-related olfactory signatures in urine. The platform generates structured biological data that is largely missing from today's AI-for-biology landscape, opening downstream applications beyond the first product.
The clinical goal is to make early cancer screening faster, less invasive, and more accessible, shifting from complex centralized diagnostics to population-scale solutions. D-Tails focuses on urine as a patient-friendly and operationally scalable biological matrix, unlike most emerging screening solutions built around blood-based or complex molecular workflows.
The technology is designed around three core advantages: non-invasive sampling, rapid readout, and low-cost scalability. Early work based on living olfactory models has produced promising experimental results, while the next development phase centers on a multiplexed receptor-based readout capable of producing a cancer-risk fingerprint from a urine sample.
D-Tails is entering a scale-up phase supported by European funding. Its roadmap covers pre-clinical and clinical validation, CE-IVD regulatory preparation, manufacturing scale-up, and a gradual transition from a laboratory service model toward product-based deployment.
The company is led by an experienced board and scientific team combining expertise in life sciences, photonics, engineering, intellectual property, and corporate finance. Its broader ecosystem includes leading academic, clinical, and research institutions in Europe.
